share_log

Immuneering Q1 EPS $(0.49) Misses $(0.46) Estimate

Immuneering Q1 EPS $(0.49) Misses $(0.46) Estimate

Immuneering 第一季度每股收益(0.49 美元)未达预期(0.46 美元)
Benzinga ·  05/07 17:02

Immuneering (NASDAQ:IMRX) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.46) by 6.52 percent. This is a 3.92 percent increase over losses of $(0.51) per share from the same period last year.

Immuneering(纳斯达克股票代码:IMRX)公布的季度亏损为每股0.49美元,比分析师普遍预期的0.46美元(0.46美元)低6.52个百分点。这比去年同期每股亏损0.51美元(0.51美元)增长了3.92%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发